time trial, in a group that were told their performance would be increased by 84 carbohydrate administration, regardless of whether they eventually received 85 carbohydrate or placebo. 86
87
Contrary to this, ambiguity surrounding the proposed treatment may produce results 88 that are incongruent with expectation (Foad, Beedie and Coleman, 2008) . More 89 specifically, Foad et al. (2008) reported that the effects of caffeine were greatest when 90 participants believed that they had not ingested caffeine as opposed to when they 91 believed they had. The mere presence of potential placebo and/or a placebo design 92 made individuals question treatment allocation and thus had a contradictory effect on 93 the anticipated outcome. Despite the link between expectation and the placebo effect, 94 few studies have assessed this experimentally in the sports science domain (Pollo, 95 Carlino and Benedetti, 2008) . A better understanding here may help to clarify the 96 relationship between the effect an individual expects to experience, and the actual 97 experience itself. A meta-anlysis by Berdi, Koteles, Szabo, and Bardos (2011) has 98 established that further research is needed to determine the importance of the placebo 99 effect on sports performance and that a more balanced placebo design is required 100 along with comparing a no treatment group. Therefore, the current investigation 101 aimed to explore the effects of inert sugar free drinks described either as 'performance 102 enhancing' (Sports performance drink -placebo) or 'fatigue inducing' (nocebo) or 103 plain water on peak minute power (PMP;W) during an incremental arm crank Twelve, healthy, non-specifically trained, able-bodied male individuals volunteered to 116 take part in the study (mean ±SD age: 25.3 ± 4.4 years; weight: 80.5 ± 16.9 kg; 117 height: 178.8 ± 4.4 cm). Participants volunteered to take part on the basis that they 118 would received the outcome of the study but no financial incentive was provided. 119
Participants were injury free at the time of data collection and provided written 120 informed consent.
University Ethics Committee approval for the study's 121 experimental procedures was obtained and followed the principles outlined in the 122
Declaration of Helsinki. 123 124
Design: 125 126
Participants were required to perform three separate (one week apart), incremental 127 tests using a Monark arm crank ergometer (Monark Inc, London UK) to determine 128 PMP;W. Thirty minutes prior to each test, participants were required to drink either 129 500ml of water, or the same volume of a 'sports performance' (placebo) or 'fatigue 130 inducing' drink (nocebo). These drinks were in fact identical commercial sugar -free 131 drinks that had no known physiological effect on performance. The study was 132 performed in a randomized cross over design and was single blinded.
134
Prior to the relevant test, a standardized written script was handed to the participant's. Oxygen consumption (VO 2) respiratory exchange ratio (RER), carbon dioxide 155 production (VCO 2 ) and minute ventilation were analysed using an online breath-by-156 breath analysis system (Cosmed Quark b 2 metabolic analyse-gas analysis) and 157 averaged over the final 15 seconds of each workload, and over the final 15 seconds of 158 the test for peak responses. Heart rate (HR) was monitored using a heart rate monitor, 159
and measured at the same intervals (Price, Bottoms, Smith and Nicholettos, 2011). 160
Fingertip blood samples were collected at volitional exhaustion and analysed for 162 blood lactate concentration (Analox GM7, Surrey, UK). Ratings of perceived exertion 163 for local working muscles (LRPE) and cardio-respiratory (CRPE) components of 164 effort perception (Borg Scale) were recorded during the last 15 seconds of each 165 exercise stage and at volitional exhaustion (Price et al., 2011) . 166
167
After the third test, participants were asked to identify (using a Likert scale from 1 to 168 10) the degree to which they expected the sports performance drink would positively 169 impact their performance (1 being not at all, 5 to some extent and 10 being very much 170 so), and the degree to which they expected the nocebo drink would decrease their 171 performance (1 being very much so, 5 to some extent and 10 being not at all). 172
Following this, they were informed about the true nature of the experiment and why 173 deception was a fundamental component. 174
175

Statistical analysis 176
All data was analysed using SPSS version 20.0. The Shapiro-Wilk statistic confirmed 177 that the normal distribution assumption was met for all variables. Therefore, a 178 repeated measures one-way ANOVA was used to assess differences in PMP:W 179 between trials, post blood lactate values, and expectation scores (Likert scale). A 180 two-way ANOVA for repeated measures was used to assess the main effect of time, 181 group, and time -group interactions for physiological variables: heart rate, VO 2 , 182 VCO 2 , RER, VE, and subjective ratings of central and local RPE values. Appropriate 183 post-hoc analyses were conducted using a Bonferroni correction to control for type I 184 error. Partial effect sizes were calculated using an η 2 . Spearman's rank correlation co-185 efficients were used to explore the relationship between the extent to which theparticipants expected (likert score) the two drinks would increase (placebo)/ decrease 187 Spearman's rank correlation co-efficients revealed a significant correlation (rho= 0.85 234 ; p < .001) between individuals who had the greatest increase in PMP;W (compared to 235 water) and those who had the highest expectation of the placebo drink (Likert). 236
Similarly, a significant weak correlation was found between individuals who had the 237 largest decrease in performance (compared to water) and individuals with the highest 238 expectation of the nocebo drink (Figures 1 and 2 respectively) . including the mode of exercise and its outcome measure, and the duration of the study 257 make direct comparisons difficult. The present study used a water trial as a no 258 treatment group to more accurately assess the extent of the placebo effect as 259 suggested by Berdi et al. (2011) . The collective data do suggest that the placebo can 260 exert its effect across several exercise modalities and protocols of different durations. 261
262
Contrary to the hypothesis the nocebo drink failed to cause a significant decrease in 263 performance. This asymmetry between the placebo and nocebo may be due to 264 discrepancies in the participant's appreciation of the two drinks. That is, participants 265 better understood that a drink could increase, rather than decrease performance. 266
Statistical tests suggested that there was no significant difference in the expectation 267 assigned to the two drinks (Likert scale). This finding may highlight a possiblelimitation of the Likert scale and it may not be sensitive enough to determine 269 differences, compared to qualitative equivalents. In addition, the likert scale was 270
given after the test and may therefore not completely reflect their expectation prior to 271 the test. In future the scale should be presented prior to the test to more accurately 272 measure the expectation of the drink. It may also be reasonable to suggest that a 273 fatigue inducing drink may not be the best method of activating a nocebo response. 274
275
It is important to highlight an observation from the current investigation that provides 276 evidence for the nocebo. Evidence for a nocebo response was the response of LRPE 277 with the nocebo causing a significant increase in LRPE compared to water and the 278 placebo. These data add to previous data that suggest that expectations alter somatic 279 The current study used well -defined objective physiological measures to identify a 290 maximal effort to limit potential suggestions that the 'placebo effect' was simply 291 attributable to participants trying harder (Kalasountas et al., 2007) . 292
The current investigation used a Likert scale, in order to identify the relationship 294 between the expectation of a change in performance and those individuals with who 295 had the greatest change in PMP;W. This assessment tool was easy to use, and 296 significant correlations were found between individuals with the highest expectations 297 of the placebo and nocebo drink and individuals who subsequently had the greatest 298 changes in PMP; W compared to the water trial. However, this scale failed to identify 299 any individual factors that may have increased an individual's expectations of the two 300 drinks, possibly because it was presented after the test rather than prior to the test. 301
This may be particularly important since not all participants experienced a placebo/ 302 nocebo effect. Qualitative data may have provided more information about individual 303 experiences, and should feature in future research (Mengshoel, 2012) . the knowledge that a drink has been consumed that is 'sport enhancing'. This may 317 manifest in a situation like that seen in the current investigation where an increase inPMP';W is observed despite there being no significant difference between the groups 319 for objective physiological markers. 320 321
In conclusion, the current investigation reported a significant increase in PMP; W 322 together with a decrease in LRPE, following the ingestion of an inert 'sports 323 performance' drink. The current study failed to report a significant nocebo effect on 324 PMP;W. However, a significant increase in LRPE was observed compared to water 325 and the placebo drink. These results suggest that the time has come to broaden our 326 
